Literature DB >> 6461590

Inducer and suppressor T-cells in hepatitis B virus-induced liver disease.

H C Thomas, D Brown, G Routhier, G Janossy, P C Kung, G Goldstein, S Sherlock.   

Abstract

During acute type B hepatitis, the proportion of inducer to cytotoxic/suppressor T-cells is decreased due to an increase in the concentration of suppressor cells. Similar changes are seen in chronically infected subjects with evidence of active viral replication (HBeAg positive) and chronic hepatitis of varying severity. This imbalance of the regulatory cells returns to normal when viral replication decreases during the recovery phase of acute hepatitis and in patients who become chronic carriers with minimal liver disease (HBeAb positive patient). Patients in whom viral replication has subsided (HBeAb positive) but who continue to exhibit chronic active liver disease have increased inducer to cytotoxic/suppressor cell ratios due to a decrease in the concentration of the cytotoxic/suppressor cell population. Further studies are needed to determine whether these alterations of the regulatory cells of the immune system are a causal factor influencing the duration of active hepatitis B virus replication and the degree of inflammatory liver damage, or merely changes secondary to the presence of a replicating virus.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6461590     DOI: 10.1002/hep.1840020203

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  21 in total

1.  Interleukin-1 and -2 in sera of patients with chronic hepatitis (type B).

Authors:  T Ozeki; K Imanishi; H Unoki; K Funakoshi; Y Kiya
Journal:  Int J Exp Pathol       Date:  1990-12       Impact factor: 1.925

2.  Functional characterization of peripheral blood lymphocytes in chronic HBsAg carriers.

Authors:  G J Alexander; M Mondelli; N V Naumov; K T Nouriaria; D Vergani; D Lowe; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

3.  Humoral and cellular immune responses by normal individuals to hepatitis B surface antigen vaccination.

Authors:  L G Filion; R Saginur; N Szczerbak
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

4.  Circulating hepatocyte membrane-specific autoantibodies in chronic active hepatitis type B. Relation to virus replication activity and liver cell necrosis.

Authors:  R Meliconi; M Baraldini; A Alberti; F Bortolotti; G Realdi; A Facchini; G Gasbarrini; G Labo
Journal:  Dig Dis Sci       Date:  1984-07       Impact factor: 3.199

5.  Peripheral blood mononuclear cells and regulatory T cells in acute viral hepatitis.

Authors:  V Barnaba; E Tamburrini; V Laghi; R Cauda; M Levrero; G Ruocco; L Ortona; F Balsano
Journal:  Gut       Date:  1985-07       Impact factor: 23.059

6.  Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection.

Authors:  A Kalinkovich; Z Weisman; Z Greenberg; J Nahmias; S Eitan; M Stein; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

7.  Effects of adenine arabinoside on cellular immune responses in patients with chronic hepatitis B.

Authors:  I Hyodo; G Yamada; K Manabe; H Okushin; M Mizuno; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1986-06

8.  Peripheral T-lymphocyte subpopulations in different clinical stages of chronic HBV infection correlate with HBV load.

Authors:  Jing You; Lin Zhuang; Yi-Feng Zhang; Hong-Ying Chen; Hutcha Sriplung; Alan Geater; Virasakdi Chongsuvivatwong; Teerha Piratvisuth; Edward McNeil; Lan Yu; Bao-Zhang Tang; Jun-Hua Huang
Journal:  World J Gastroenterol       Date:  2009-07-21       Impact factor: 5.742

9.  Cellular immune responses in the acute exacerbation of hepatitis B e antigen-positive type B chronic hepatitis.

Authors:  I Hyodo; G Yamada; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1985-08

10.  Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis.

Authors:  M Bofill; G Janossy; C A Lee; D MacDonald-Burns; A N Phillips; C Sabin; A Timms; M A Johnson; P B Kernoff
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.